It is with mixed emotions we announce that Jennifer Bright, MPA, will be stepping down from her position as Chief Strategy and Engagement Officer effective June 30th. Ms. Bright joined IVI in 2017 and served as the organization's first Executive Director and then Chief Executive Officer until July 2022, when she transitioned into her [...]
Alexandria, VA – June 14, 2023 – The Innovation and Value Initiative (IVI), a non-profit research organization committed to advancing the science, practice, and use of health technology assessment (HTA) in healthcare, today announced the release of its proceedings report from the 2023 IVI 4th Annual Methods Summit, Rewriting the Playbook on Health Technology [...]
Alexandria, VA – June 7, 2023 – The Innovation and Value Initiative (IVI), a non-profit research organization committed to advancing the science, practice, and use of health technology assessment in healthcare, in partnership with AcademyHealth, released a joint report, "A Research Framework to Understand the Full Range of Economic Impacts on Patients and Caregivers," [...]
IVI, in partnership with AcademyHealth, released a joint report, “A Research Framework to Understand the Full Range of Economic Impacts on Patients and Caregivers,” for researchers, value assessors, and other decision-makers to address the full range of economic impacts on patients. This report was made possible through funding support from the Eugene Washington PCORI [...]
Richard Seiden, retired attorney and patient advocate, is a member of the IVI Patient Advisory Council, where he provides valuable insight into IVI's work. In a recent conversation, Richard shared how psoriatic arthritis has impacted his life and why he works with IVI to center the patient within the health technology assessment process. [...]
Alexandria, VA – May 5, 2023 – The Innovation and Value Initiative (IVI), a non-profit research organization committed to advancing the science, practice, and use of health technology assessment (HTA) in health care, submitted comments on the Centers for Medicare & Medicaid Services (CMS) initial guidance on the implementation of the Medicare Drug Price Negotiation Program [...]
IVI submitted comments on the Centers for Medicare and Medicaid Services' (CMS) initial guidance for the implementation of the Medicare Drug Price Negotiation Program (Medicare DPNP). We appreciate the opportunity to provide comment on this important issue. Read our full comments here. ### About IVI The Innovation and Value Initiative (IVI) is a [...]
IVI is pleased to share our recently published manuscript, co-authored with the RAND Corporation, in the Journal of Comparative Effectiveness Research. For this manuscript, IVI collaborated with a steering committee and surveyed patients with rheumatoid arthritis (RA) to discover a new method for engaging patients in healthcare valuation using patient-specific goals. The findings indicated [...]
In 2021, the Innovation and Value Initiative (IVI) and the Arthritis Foundation published a report, First Hand Perspectives in Rheumatoid Arthritis, describing how researchers often miss the priorities and needs of people living with rheumatoid arthritis (RA). Each of the patient-advocate co-authors reiterated that the costs related to RA reach far beyond direct medical [...]
Alexandria, VA – March 28, 2023 – The Innovation and Value Initiative (IVI), a non-profit research organization committed to advancing the science, practice, and use of value assessment in health care, today announced the addition of seven new members to its Patient Advisory Council (PAC): Kelly Barta (Coalition for Skin Diseases), Elridge Proctor, MPA (GO2 [...]
